Award
NIH Reporter #1F31HL184854-01
Optimization of enhanced in situ protein production for FVIII replacement using modular, rationally designed translatable ribonucleic acids expressing self-replicative machinery
Recipient
Boston University (Charles River Campus)
Award Amount
$43,321.00
Ceiling
$43,321.00
Awarded
August 06, 2026
Identifier
1F31HL184854-01
A National Heart, Lung, and Blood Institute fellowship supports Wyatt Becicka’s research and training at Boston University to develop self-amplifying RNA approaches for improved factor VIII replacement therapy.
Description
Fellowship research to develop self-amplifying RNAs for factor VIII protein replacement therapy, including optimizing RNA delivery, replication, safety, efficacy, and immune response.